Record Clinical and Financial Results
Ensign Group posted record clinical and financial results with significant growth in occupancy and skilled mix, reflecting strong market performance across their portfolio.
Occupancy and Skilled Mix Growth
Same-store and transitioning occupancy increased by 2.7% and 4.1%, respectively, for the year. Skilled days grew by 3.8% for same-store and 10.9% for transitioning operations. Managed care census rose by 6.6% and 27.7% for same-store and transitioning operations, respectively.
Strong Revenue and Earnings Growth
Total revenue increased by $2.2 billion over the last five years, representing a 109.2% increase. Diluted GAAP earnings per share grew by a compound annual growth rate of 25.6% from 2019 to 2024.
Expanded Operations and Acquisitions
Ensign Group added 57 operations across different markets, including 12 new operations during the quarter, enhancing their presence in states like Tennessee and Alabama.
2025 Guidance
Issued 2025 earnings guidance of $6.16 to $6.34 per diluted share and annual revenue guidance of $4.83 billion to $4.91 billion, signaling continued growth expectations.
Dividend and Deleveraging
Increased dividend for the 22nd consecutive year and achieved a record low lease-adjusted net debt to EBITDA ratio of 1.9 times.